Purchasing medicines for the public sector: Evaluation of the performance of centralised procurement in Portugal

Vogler, Sabine; Habimana, Katharina; Haasis, Manuel Alexander

doi:10.1002/hpm.3444

Cited by 4 publications

(1 citation statement)

References 57 publications

(107 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many countries from low-middleincome to high-income have adopted centralized procurement (or named "pooled procurement") of medicines to control drug expenses (Dubois et al, 2021;Parmaksiz et al, 2022). For instance, in Denmark and Norway the respective central procurement agencies purchase the medicines for all public hospitals (Vogler et al, 2022). China has implemented NCDP policy by summarizing international experience.…”

Section: Introductionmentioning

confidence: 99%

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

Huang

Wang²,

Tao³

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Background: National Centralized Drug Procurement (NCDP), an ongoing government-led policy starting in 2019 in China, aimed at reducing drug costs. During the implementation of NCDP, healthcare professionals (HCPs) still have a certain degree of concern about the policy, which affects the clinical use of related drugs.Objective: This study aims to assess the level of knowledge, attitude and practice (KAP) of HCPs towards NCDP policy, together with the associated factors that determine their KAP.Methods: A cross-sectional study was conducted between September and November of 2021 in 30 hospitals in Hubei province in Central China. A self-designed online questionnaire including KAP towards NCDP policy was administered to HCPs. Logistic regression analysis was adopted to identify the factors associated with KAP.Results: A Total of, 742 HCPs completed the questionnaires. 43.4% of HCPs had good knowledge, 24.7% had a positive attitude, and 23.7% held good practice. Through multivariate logistic regression analysis, HCPs who are males, pharmacists, with senior professional titles and 6–10 years of professional working experience contributed to a higher knowledge level. Pharmacists and HCPs with good knowledge were more likely to have positive attitudes, while HCPs with higher education were less likely to have positive attitudes. Pharmacists, HCPs who had 11–20 years of professional working experience, worked in medium-size urban areas or had good knowledge were more likely to have good practice. Good practice is also associated with the positive attitude towards the efficacy of centralized-purchased medicines and impacts of NCDP policy.Conclusion: Only a small percentage of HCPs had good KAP towards NCDP policy. Pharmacists showed better KAP than physicians. The positive attitude towards the efficacy of centralized-purchased medicines and impacts of NCDP policy contributed to better practice. High-quality clinical evidence on the therapeutic effects and safety of the centralized-purchased drugs is needed.

show abstract

Section: Introductionmentioning

confidence: 99%

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

Huang

Wang²,

Tao³

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Market Transparency in Medicine Pricing: Pathways to Fair Pricing

Carapinha

2024

PharmacoEconomics

View full text Add to dashboard Cite

Comparative Analysis of the European Centralised Public Procurement

Tátrai,

Vörösmarty

2023

Central European Journal of Public Policy

View full text Add to dashboard Cite

When analysing centralised public procurement models and solutions from the public administration point of view, attention needs to be paid to the specific features of public procurement as well as the institutional characteristics of the major central procurement organisations. In this paper, central procurement organisations in 11 European countries were compared based on interviews according to their activities, market positions and institutional characteristics. We shall address the issue of efficiency and stability of organisational structures by comparing the practice of the Central and Eastern European (CEE) and non-CEE European Countries. This comparison analyses the differences of the countries’ centralised public procurement structures and reveals the diversity of analytic criteria, underlining that the legal regulatory background to public procurement is not necessarily predominant in determining specific features and characteristics. The stability and market-oriented characteristics of a centralised public procurement system have an impact on the innovativeness of central purchasing bodies (CPBs) and on the development of their service provider nature, which should be taken into account by the CEE countries with a less-developed public procurement culture.

show abstract

Purchasing medicines for the public sector: Evaluation of the performance of centralised procurement in Portugal

Cited by 4 publications

References 57 publications

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

Market Transparency in Medicine Pricing: Pathways to Fair Pricing

Comparative Analysis of the European Centralised Public Procurement

Contact Info

Product

Resources

About